DENVER--(BUSINESS WIRE)--MuscleSound, the creator of a patented software technology and methodology to detect and prevent soft-tissue muscle injuries and improve athletic performance, today announced that it has initiated a $5mm private placement offering solely to accredited investors (the “Offering”) under Rule 506(c) of Regulation D promulgated by the SEC under the Securities Act.
The company will use the proceeds from the Offering for global expansion including the costs associated with new hires, growth in key sports verticals and expansion into the healthcare marketplace—expanding research in the importance of glycogen in preventative care and recovery management.
“MuscleSound has redefined injury prevention, improved athletic performance and through our intimate muscle knowledge, we have optimized nutrition for athletes around the world,” said Stephen Kurtz, MuscleSound’s co-founder and Chief Executive Officer. “We are excited to offer investors an unprecedented opportunity to invest in our company, fueling our growth into the healthcare and sports markets.”
Athletes’ fueling and recovery needs change throughout the season. By measuring glycogen, the body’s primary energy source during periods of high-energy exertion, MuscleSound enables athletes and teams to monitor and iterate nutritional needs over time. After taking an ultrasound scan of a muscle, MuscleSound sends the image to its cloud-based software, which generates results in about 15 seconds. Team leaders gain insight into the effects of nutrition, injury prevention, recovery times and performance levels. Over the last calendar year, MuscleSound has continued to grow: partnering with 10 NCAA universities, most recently signing on Oregon State, the University of Colorado and the University of South Carolina. Professional teams that currently leverage MuscleSound include, but are not limited to, the Colorado Rockies, Dallas Mavericks, Philadelphia Flyers, several global Olympic teams and soccer clubs in the United Kingdom.
“MuscleSound has developed a game-changing solution for the treatment of soft tissue injuries,” said Andy Brusman, CEO of Alchemy Global Holdings. “The technology is a must have for sports teams, physical therapists and health systems who are treating athletes at any level. We are excited to assist with the capital raise as well as work with the team at MuscleSound to help expand their business globally.”
To learn more about the MuscleSound offering please contact Andy Brusman at abrusman@alchemyglobal.com or call 843-654-9365.
Accredited Investor Definition
While general solicitation of Rule 506(c) offerings is now permitted, purchasers in a Rule 506(c) offering must be "accredited investors." The SEC defines the term "accredited investor" in Rule 501(a). Generally, individuals are considered accredited investors if they have a net worth greater than $1 million (excluding their primary residence) or incomes in excess of $200,000 in the last two years with the expectation of the same in the current year (or $300,000 with a spouse).
About MuscleSound
MuscleSound® patented software technology and methodology has made non-invasive, real-time measurement of muscle glycogen (energy) content levels a reality. The MuscleSound methodology delivers prompt and precise data that allows for proactive performance and health-based recommendations to effectively optimize overall recovery and injury prevention.
About Alchemy Global Holdings, LLC
Alchemy, headquartered in Charleston, SC with offices in London, Boston, MA and Baltimore, MD, is the first dedicated sports, media and entertainment investment portal operating under Title II of the Jobs Act. The company provides capital raising and advisory services to emerging growth companies in verticals such as consumer products, endurance and mass participation sports, services, traditional and digital media, intellectual property, health and wellness and technology. The company's management team has significant operating experience and expertise in building and growing businesses around the world. They leverage this expertise in developing product differentiation, diversified customer bases, strong management and financial performance for its clients. Investors in Alchemy include some of the savviest entrepreneurial minds in sports and entertainment as well as athletes turned entrepreneurs Greg Norman, Jim Courier and Boris Becker.
Alchemy Global Holdings, LLC (“Alchemy”) is not a registered broker-dealer. Securities offered are through Merriman Capital Inc, a registered broker dealer and member FINRA/SIPC. Offerings listed on this site are only made to US investors, they do not constitute a solicitation outside of the US and only US investors may invest. Alchemy does not give investment advice, endorsement, analysis or recommendations with respect to any securities.
